GENESIS Biomed
Consultancy providing creation and early lifecycle support for biomedical spin-offs, start-ups and research centres. Services include business planning, fundraising and investor support, venture building and management of early-stage investment vehicles, regulatory and CMC advisory, technology transfer support and coordination of outsourced R&D. Headquartered at Parc Científic de Barcelona with additional sites in Madrid and Valencia. Reported activity: ~400 projects, ~225 clients, 21 closed financing rounds and ~€80M raised for clients; manages early-stage investment vehicles with several million euros of investible capital.
Industries
Nr. of Employees
small (1-50)
GENESIS Biomed
Barcelona, Catalonia, Spain, Europe
Products
Early-stage investment vehicles
Managed vehicles providing seed capital and operational support to accelerate early-stage research projects into companies and follow-on funding rounds; includes vehicles focused on tech-transfer and translational research.
Early-stage investment vehicles
Managed vehicles providing seed capital and operational support to accelerate early-stage research projects into companies and follow-on funding rounds; includes vehicles focused on tech-transfer and translational research.
Services
Combined business planning, investor materials, fundraising strategy, financial modelling and transaction readiness for early-stage biomedical projects.
Regulatory roadmap definition, IP landscape and freedom-to-operate assessments, quality management system implementation and accreditation support.
Definition of required preclinical/clinical studies, milestone planning, timeline generation and identification of suitable outsourced partners.
Operational venture-building support and managed early-stage investment vehicles to accelerate translation of research into companies.
Support for digital health projects, payer partnerships and deployment strategy for AI and telemedicine solutions.
Interim executive roles, board observer participation and ongoing strategic mentoring and operational integration with client teams.
Combined business planning, investor materials, fundraising strategy, financial modelling and transaction readiness for early-stage biomedical projects.
Regulatory roadmap definition, IP landscape and freedom-to-operate assessments, quality management system implementation and accreditation support.
Definition of required preclinical/clinical studies, milestone planning, timeline generation and identification of suitable outsourced partners.
Operational venture-building support and managed early-stage investment vehicles to accelerate translation of research into companies.
Support for digital health projects, payer partnerships and deployment strategy for AI and telemedicine solutions.
Interim executive roles, board observer participation and ongoing strategic mentoring and operational integration with client teams.
Expertise Areas
- Startup and spin-off formation
- Fundraising and investor relations
- Venture building and seed investing
- Regulatory strategy and CMC advisory for medtech and biopharma
Key Technologies
- Digital health platforms
- AI-driven diagnostics
- Telemedicine platforms
- Mobile health (mHealth) applications
News & Updates
Received an award for best biomedical consultancy in the XI Edition of the National Awards El Suplemento.
Participation in strategic development of a therapeutics company that later licensed a drug candidate to a larger pharmaceutical company.
Provided valuation support for a diagnostics company that was subsequently acquired.
Organised and held the company's 2025 annual symposium at the Parc Científic de Barcelona.
Sponsorship and active participation in the BIOSPAIN 2025 event.
Received an award for best biomedical consultancy in the XI Edition of the National Awards El Suplemento.
Participation in strategic development of a therapeutics company that later licensed a drug candidate to a larger pharmaceutical company.
Provided valuation support for a diagnostics company that was subsequently acquired.
Organised and held the company's 2025 annual symposium at the Parc Científic de Barcelona.
Sponsorship and active participation in the BIOSPAIN 2025 event.